|
TRIM23 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.487170E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.663400E-03 |
| Normal-vs-Stage2 |
3.820200E-01 |
| Normal-vs-Stage3 |
6.663000E-01 |
| Normal-vs-Stage4 |
2.955800E-01 |
| Stage1-vs-Stage2 |
6.969800E-01 |
| Stage1-vs-Stage3 |
9.980200E-03 |
| Stage1-vs-Stage4 |
4.338400E-03 |
| Stage2-vs-Stage3 |
2.923200E-01 |
| Stage2-vs-Stage4 |
1.656610E-01 |
| Stage3-vs-Stage4 |
5.778600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.065370E-01 |
| Normal-vs-AfricanAmerican |
8.019800E-01 |
| Normal-vs-Asian |
7.183600E-01 |
| Caucasian-vs-AfricanAmerican |
2.792000E-01 |
| Caucasian-vs-Asian |
9.914200E-01 |
| AfricanAmerican-vs-Asian |
6.816000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.666000E-01 |
| Normal-vs-Female |
8.053800E-02 |
| Male-vs-Female |
3.072400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.273030E-01 |
| Normal-vs-Age(41-60Yrs) |
9.117500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.254800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.697800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.796220E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.209900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.083400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.851800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.360200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.564000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.257180E-01 |
| Normal-vs-Grade 2 |
4.038400E-03 |
| Normal-vs-Grade 3 |
4.162000E-01 |
| Normal-vs-Grade 4 |
5.980000E-04 |
| Grade 1-vs-Grade 2 |
2.529000E-01 |
| Grade 1-vs-Grade 3 |
1.733200E-01 |
| Grade 1-vs-Grade 4 |
2.496400E-02 |
| Grade 2-vs-Grade 3 |
4.928300E-02 |
| Grade 2-vs-Grade 4 |
1.91719999875772E-08 |
| Grade 3-vs-Grade 4 |
8.45740000000594E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.76090000003626E-06 |
| Normal-vs-ccB subtype |
2.369800E-01 |
| ccA subtype-vs-ccB subtype |
4.23439999730491E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.071600E-02 |
| Normal-vs-N1 |
2.348400E-01 |
| N0-vs-N1 |
1.143800E-01 |
|
|
